Evaluation of Safety and Tolerability of Ocular Lubricants

Evaluation of Safety and Tolerability of Ocular Lubricants

The purpose of this study is to evaluate the safety profile of test formulations for an artificial tear product versus a comparator product.

Subjects will be randomized to one of five different treatment sequences. Subjects will attend 6 scheduled visits with an expected individual duration of participation of 11 to 42 days. This study will be conducted in Australia.

Key Inclusion Criteria:

• Able to understand and sign an informed consent form.
• Willing and able to attend all study visits as required by the protocol.
• Other protocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Any known active ocular disease.
• Any systemic condition that, in the opinion of the investigator, may affect a study outcome variable.
• Any ocular injury to either eye in the past 12 weeks prior to screening.
• Other protocol-defined exclusion criteria may apply.